Core Laboratories
CLB
198 hedge funds and large institutions have $1.19B invested in Core Laboratories in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 56 increasing their positions, 75 reducing their positions, and 26 closing their positions.
16% more call options, than puts
Call options by funds: $2.48M | Put options by funds: $2.15M
15% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 26
2% more funds holding
Funds holding: 195 → 198 (+3)
6.11% less ownership
Funds ownership: 98.62% → 92.51% (-6.1%)
25% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 75
33% less capital invested
Capital invested by funds: $1.78B → $1.19B (-$588M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$20.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$9.75M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$5.68M |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$5.35M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$5.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
AKO Capital
London,
United Kingdom
|
-$53.2M |
| 2 |
FAM
Fred Alger Management
New York
|
-$22M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$18.1M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.34M |
| 5 |
Morgan Stanley
New York
|
-$9.07M |
CLB Hedge Fund Activity: Q3 2021 in Review
198 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2021, worth a combined $1.19B — down 33% from $1.78B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new CLB positions and 26 closed out — a net gain of 4 holders — while 56 added to existing stakes and 75 trimmed.
The largest buyer was Ariel Investments, adding an estimated $20.7M. The largest seller was AKO Capital, exiting entirely with an estimated $53.2M sold.
- 198 institutional investors held Core Laboratories (CLB) as of Q3 2021, up from 195 in Q2 2021.
- Funds reported $1.19B of Core Laboratories stock for Q3 2021, down 33% quarter-over-quarter.
- 30 funds opened new Core Laboratories positions in Q3 2021 and 26 closed out, a net change of +4 holders.
- The largest Core Laboratories buyer in Q3 2021 was Ariel Investments, an estimated $20.7M added.
- The largest Core Laboratories seller in Q3 2021 was AKO Capital, an estimated $53.2M sold.
Based on aggregated 13F filings for Q3 2021.